Products	more

　　　Recombinant HEV Vaccine

　　　　CHARACTERISTICS

　　　E.coil expressed, non-fusion 240 amino acids length fragment of HEV capsid protein (ORF2)

　　　>95% purification

　　　Self-agggregated into virus like particle (VLP) after purification

　　　Alum adjuvant, 20 ug/dose

　　　Suggested immunized program: 0,1m,6m

　　　　STATUS

　　　It is under phase II clinical trial now, and will enter phase III soon.